History - Farabloc

About Farabloc

Farabloc Development Corporation

Farabloc Development Corporation Established in 1983

The Farabloc Development Corporation is a private company that designs, develops and manufactures Farabloc EMFshielding products and clothing.

The corporate mission of the Farabloc Development Corporation is to develop Farabloc as a mainstream international fitness and rehabilitation product that can be used to reduce pain from muscle damage suffered by injured workers, athletes and amputees.

The Farabloc Timeline

Research Papers are located here

2006
2006 Awaiting Publication in the Clinical Rheumatology ( UK ) : " Efficacy of Farabloc as an Analgesic in Primary Fibromyalgia "

2005
CANBERRA, AUSTRALIA - Double-Blind Cross Over Study on The Efficacy of Farabloc in the Management of Chronic Anterior Knee Pain in Athletes by The Australian Institute of Sport.

2004
United Kingdom University of York, U.K. Centre for Reviews and Dissemination Dare Abstract 20020730 Systematic Review of Clinical Journal of Pain, 2002; 18(2):84-92.

2004
BC Chiropractic Association endorses Farabloc.

2002
2002 Australia A Systematic Review: Evidence for the Optimal Management of Acute and Chronic Phantom Pain by Julie Halbert, M. Sc., Maria Crotty, Ph.D, Ian D. Cameron, Ph.D. Publication: The Clinical Journal of Pain, 2002; 18:84-92

2002
THE CLINICAL JOURNAL OF PAIN, Philadelphia, PA, 18(2): 84-92, March/April, 2002 PMID: 11882771 [PubMed - indexed for MEDLINE]

2001
THE BRITISH COLUMBIA MEDICAL JOURNAL, 43: 10; Pages 573-577; December, 2001.

2000
Health Canada: Medical Device Establishment Licence

2000
THE CLINICAL JOURNAL OF SPORT MEDICINE, Philadelphia, PA, 10(1): 15-21, January, 2001 PMID: 10695845 [PubMed - indexed for MEDLINE]

1999
FDA Establishment Registration and Device Listing for Farabloc-LC (Limb Cover)

1999
Farabloc becomes a NAFTA member

1999
Canadian Academy of Sport Medicine Award

1999
"Study of The Efficacy of FARABLOC in the Treatment of Fibromialgia" in progress, by Prof. G.L. Bach, Bensheim, Germany.

1998
THE UNIVERSITY OF BRITISH COLUMBIA "The Efficacy of FARABLOC in Reduction of Delayed Onset Muscle Soreness."

1993
THE CANADIAN JOURNAL OF REHABILITATION:" Publication of the University Study: "The Efficacy of FARABLOC in the Treatment of Phantom Limb Pain."

1992
Completion of the Double Blind Cross-Over Designed University Study, carried out under a contract funded by the British Columbia Ministry of Health "The Efficacy of FARABLOC in the Treatment of Phantom Limb Pain."

1991
Clinical trials conducted by Dr. J.D. Twidale, M.A., Vet.M.B., M.R.C.V.S., Equine veterinarian -
"Changes in Blood Count and Blood Chemistry while wearing Equusbloc (FARABLOC) blanket"
Remarkable decrease of CPK enzyme

1989
Permission granted by the Office of Research Services of the University of British Columbia in Vancouver, B.C., to conduct a double-blind crossover study.

1989
U.S. Patent, EQUUSBLOC, also granted for use in veterinary treatment.

1988
1987
Conclusion of tests and studies, promoted by the Federal Government of Germany in Bonn and conducted by the Bavarian Ministry (STMAS) in the Department of Supply and Services, with no less than 68% success.

1987
U.S. patent granted.

1985
Various studies and tests are conducted by health organizations and insurance companies in Bayeurth, Germany by Dr. G.L. Bach, formerly Professor and Chairman, Department of Clinical Immunology and Rheumatology - Chief, University of Loyola - Medical Division at the Cook County Hospital, Chicago, Illinois (USA) and the University of Loyola, Maywood, Illinois (USA).

1984
U.S. patent pending.

1983
Incorporation of The FARABLOC Development Corporation in Canada.

1979
The first generation of products are found to give remarkable pain relief for amputees in Bavaria, Germany.

1972
Early variations of FARABLOC are developed

1969
Frieder Kempe uses the principle of the Faraday Cage to combat phantom pain. The idea was born out of necessity - to give relief to the inventor's father, Rudolf Kempe, a W.W. II amputee.

Research Papers are located here...

Farabloc is a proud member of the Better Business Bureau and meets all standards of the Better Business Bureau Online Reliability Program. Farabloc is recognized as a 15 Year Member for many years of outstanding support.

Phantom Limb Pain | Pain Relief | Amputee Resources| Farabloc News | For Professionals | Farabloc Support | Farabloc Testimonials | Farabloc Shop | Contact Farabloc | Search Farabloc | Site Map | Home

About Farabloc

Farabloc Development Corporation

Farabloc Development Corporation Established in 1983

The Farabloc Timeline

Phantom Limb Pain | Pain Relief | Amputee Resources| Farabloc News | For Professionals | Farabloc Support | Farabloc Testimonials | Farabloc Shop | Contact Farabloc | Search Farabloc | Site Map | Home

Copyright © 2005 Farabloc Development Corporation. All rights reserved. Site Design by Simply Creative for You. Website Marketing by Sky's the Limit Web Marketing.

Site-Chapters

Farabloc

High-Tech Clothing for Your Well Being

2006	2006 Awaiting Publication in the Clinical Rheumatology ( UK ) : " Efficacy of Farabloc as an Analgesic in Primary Fibromyalgia "
2005	CANBERRA, AUSTRALIA - Double-Blind Cross Over Study on The Efficacy of Farabloc in the Management of Chronic Anterior Knee Pain in Athletes by The Australian Institute of Sport.
2004	United Kingdom University of York, U.K. Centre for Reviews and Dissemination Dare Abstract 20020730 Systematic Review of Clinical Journal of Pain, 2002; 18(2):84-92.
2004	BC Chiropractic Association endorses Farabloc.
2002	2002 Australia A Systematic Review: Evidence for the Optimal Management of Acute and Chronic Phantom Pain by Julie Halbert, M. Sc., Maria Crotty, Ph.D, Ian D. Cameron, Ph.D. Publication: The Clinical Journal of Pain, 2002; 18:84-92
2002	THE CLINICAL JOURNAL OF PAIN, Philadelphia, PA, 18(2): 84-92, March/April, 2002 PMID: 11882771 [PubMed - indexed for MEDLINE]
2001	THE BRITISH COLUMBIA MEDICAL JOURNAL, 43: 10; Pages 573-577; December, 2001.
2000	Health Canada: Medical Device Establishment Licence
2000	THE CLINICAL JOURNAL OF SPORT MEDICINE, Philadelphia, PA, 10(1): 15-21, January, 2001 PMID: 10695845 [PubMed - indexed for MEDLINE]
1999	FDA Establishment Registration and Device Listing for Farabloc-LC (Limb Cover)
1999	Farabloc becomes a NAFTA member
1999	Canadian Academy of Sport Medicine Award
1999	"Study of The Efficacy of FARABLOC in the Treatment of Fibromialgia" in progress, by Prof. G.L. Bach, Bensheim, Germany.
1998	THE UNIVERSITY OF BRITISH COLUMBIA "The Efficacy of FARABLOC in Reduction of Delayed Onset Muscle Soreness."
1993	THE CANADIAN JOURNAL OF REHABILITATION:" Publication of the University Study: "The Efficacy of FARABLOC in the Treatment of Phantom Limb Pain."
1992	Completion of the Double Blind Cross-Over Designed University Study, carried out under a contract funded by the British Columbia Ministry of Health "The Efficacy of FARABLOC in the Treatment of Phantom Limb Pain."
1991	Clinical trials conducted by Dr. J.D. Twidale, M.A., Vet.M.B., M.R.C.V.S., Equine veterinarian - "Changes in Blood Count and Blood Chemistry while wearing Equusbloc (FARABLOC) blanket" Remarkable decrease of CPK enzyme
1989	Permission granted by the Office of Research Services of the University of British Columbia in Vancouver, B.C., to conduct a double-blind crossover study.
1989	U.S. Patent, EQUUSBLOC, also granted for use in veterinary treatment.
1988 1987	Conclusion of tests and studies, promoted by the Federal Government of Germany in Bonn and conducted by the Bavarian Ministry (STMAS) in the Department of Supply and Services, with no less than 68% success.
1987	U.S. patent granted.
1985	Various studies and tests are conducted by health organizations and insurance companies in Bayeurth, Germany by Dr. G.L. Bach, formerly Professor and Chairman, Department of Clinical Immunology and Rheumatology - Chief, University of Loyola - Medical Division at the Cook County Hospital, Chicago, Illinois (USA) and the University of Loyola, Maywood, Illinois (USA).
1984	U.S. patent pending.
1983	Incorporation of The FARABLOC Development Corporation in Canada.
1979	The first generation of products are found to give remarkable pain relief for amputees in Bavaria, Germany.
1972	Early variations of FARABLOC are developed
1969	Frieder Kempe uses the principle of the Faraday Cage to combat phantom pain. The idea was born out of necessity - to give relief to the inventor's father, Rudolf Kempe, a W.W. II amputee.